Intel vs TSM: Which Chip Is a Better Investment Right Now?
Intel and TSMC reported divergent earnings trajectories as AI demand reshapes chips. This analysis weighs growth, mar...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articlesStock Ultimate Dividend Safety: A Defensives Pick for 2026
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
June Signals for Top-Rated Stocks Wall Street Loves
Three Buy-rated names are drawing fresh attention in June as Wall Street echoes a defensive, cash-flow bias. AutoZone...
Micron Just Locked $100 Billion, but Is the Boom Ending?
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Apple Sinks as AI Memory Cost Surge Triggers Market Shake
Apple shares fell sharply as memory costs tied to AI infrastructure pressured margins and prompted price bumps on sel...
Bitcoin 2030: How Much Will Bitcoin Worth in the Next Era
As Bitcoin sits in the current price range, analysts lay out a spectrum of 2030 outcomes. This story unpacking scenar...
BOFA Says Micron Trading Sub-10x P/E as AI Demand Grows
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
Dell Drops Western Digital as AI Memory Boom Splits Hardware Trade
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
Anthropic Says Alibaba Used 25K Fake Accounts, Stock Slumps
Anthropic alleges Alibaba exploited thousands of fake accounts to copy AI outputs, prompting a swift stock reaction a...
Better Cloud Infrastructure Play: Alphabet vs CoreWeave
As AI workloads surge, two very different cloud players stand out: Alphabet, with its diversified cloud platform, vs ...
Spacex (SPCX) Stock Plunging: Should You Buy the Dip?
When a high-profile stock takes a sharp fall, the instinct to buy the dip can be strong. This guide breaks down how t...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...